ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Hemispherx Biopharma Inc New

Hemispherx Biopharma Inc New (HEB)

1.80
0.00
( 0.00% )
업데이트: 09:00:00

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

HEB 뉴스

공식 뉴스 전용

HEB Discussion

게시물 보기
mick mick 4 년 전
Hemispherx Biopharma (HEB)
1.8 ? 0.0 (0.00%)
Volume: 0 @-
Bid Ask Day's Range
- - - - -
HEB Detailed Quote
👍️0
Richard2 Richard2 4 년 전
I liked the original name better lol. Still think this drug has great potential, but I’m disappointed there wasn’t any news from the Japan trials.
👍️0
mick mick 5 년 전
Hemispherx Biopharma (HEB) NOW AIM
👍️0
deniseann deniseann 5 년 전
Thank you Richard, I couldn't seem to find anything on the change...
👍️0
Richard2 Richard2 5 년 전
‘AIM’ is the new ticker.
👍️0
Richard2 Richard2 5 년 전
No, the company changed its name and ticker. There’s a new board.
👍️0
deniseann deniseann 5 년 전
Is this still a real stock..?
👍️0
lowfloatwayne lowfloatwayne 5 년 전
Buying all i can it may be a long haul there is probably a reason they taking shares instead of all their pay. Hopefully a buy out.
👍️0
Richard2 Richard2 5 년 전
This drug could be huge in the me/cfs community, I really thought it would’ve received approval here in the states.
👍️0
LW89 LW89 5 년 전
They need cash so they can hit their finish and fill due in October...and they need to poly-line recertified for that to happen. They are still planning to send product to Argentina (filed the paperwork) - so regardless of what they in their PRs...someone in management is still pursuing ME/CFS where they have approvals to build on.
👍️0
lowfloatwayne lowfloatwayne 5 년 전
Their voting now to raise the share count from 2018
👍️0
lowfloatwayne lowfloatwayne 5 년 전
Acusphere has twice as many shares moves ez this should rocket eiyh the right hedge or buy out merger
👍️0
cspratt15139 cspratt15139 5 년 전
this is just sad. pure sad
👍️0
lowfloatwayne lowfloatwayne 5 년 전
Ok their not adding shares could be a 2008 run cant tell whats bottom they bought in at 2.30? Legally
👍️0
cspratt15139 cspratt15139 5 년 전
they do this to themselves
👍️0
lowfloatwayne lowfloatwayne 5 년 전
So they rs to 2.2m shares then dilute 70m shares https://seekingalpha.com/article/893871-tracking-recent-buy-calls-and-investments-by-the-maxim-group
I hope the can run a pump and dump and clay can do a video.
👍️0
aristotelisonassis aristotelisonassis 5 년 전
strong buy here. Bottom bouncer.
👍️0
cspratt15139 cspratt15139 6 년 전
Hope everyone is enjoying there weekend. Stay safe and blessed!
👍️0
cspratt15139 cspratt15139 6 년 전
Ampligen is picking up steam
👍️0
bleu22 bleu22 6 년 전
Fully funded trial up to 45-people, low float, looking for large pharmaceutical partnership, and more news on the way... I’m in. GLTA
👍️0
cspratt15139 cspratt15139 6 년 전
Going higher
👍️0
420man 420man 6 년 전
LOL..Can't even wait a few days to reward their Tutes via PR! And that's even after crushing retail for months. They will continue dumping all the way down helping shorty... I need to start shorting these plays. So damn predictable.
👍️0
bleu22 bleu22 6 년 전
They don’t even have options laid out yet. WTF
👍️0
whytestocks whytestocks 6 년 전
News: $HEB Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin

OCALA, Fla., June 12, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma Inc. announced today that the first patient has been treated in the Phase 2 recurrent ovarian cancer program at the University of Pittsburgh Medical Center (UPMC) (See: https://clinicaltrials...

In case you are interested https://marketwirenews.com/news-releases/hemispherx-biopharma-announces-first-patient-treated-in-phase-2-ovarian-cancer-clinical-trial-evaluating-ampligen-in-combination-with-pembrolizumab-and-cisplatin-8346632.html
👍️0
420man 420man 6 년 전
There's your RS... Let the shorting begin!!!
👍️0
cspratt15139 cspratt15139 6 년 전
Split coming
👍️0
420man 420man 6 년 전
.05
👍️0
Golden Cross Golden Cross 6 년 전
How low will it go before the RS is the question? I am staying out wish all GL
👍️0
whytestocks whytestocks 6 년 전
News: $HEB Hemispherx Biopharma Stockholders Approve Reverse Stock Split

OCALA, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases, today announced that its stockholders voted in...

Read the whole news https://marketwirenews.com/news-releases/hemispherx-biopharma-stockholders-approve-reverse-stock-split-8277778.html
👍️0
cspratt15139 cspratt15139 6 년 전
When is the rs
👍️0
hebbeke47 hebbeke47 6 년 전
https://www.mrknewsroom.com/news-release/oncology/merck-provides-update-phase-3-keynote-119-study-keytruda-pembrolizumab-monothe
👍️0
carldfw carldfw 6 년 전
They have investors after the rs or people to buy in. They have been selling out with each pump. Hope they have a ringer in the fda. Or 10 years later the same pumps as 2008
👍️0
Golden Cross Golden Cross 6 년 전
HEB Daily Chart:

👍️0
whytestocks whytestocks 6 년 전
News: $HEB Hemispherx Links Stanford's ME/CFS Diagnostic to a Potential Path Forward for Ampligen Commercialization

OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases — and whose product portfolio includes Amp...

In case you are interested https://marketwirenews.com/news-releases/hemispherx-links-stanford-s-me-cfs-diagnostic-to-a-potential-path-forward-for-ampligen-commercialization-8123236.html
👍️0
Golden Cross Golden Cross 6 년 전
HEB on High Alert
👍️0
tknuncle tknuncle 6 년 전
WOW that's insane!!!! Thanks for sharing the actual numbers ;)
👍️0
420man 420man 6 년 전
So the warrant exercise price has been reduced to .15?! These guys are sucker punching retail! They would be delisted already if they traded on the the NAZ. JMO

The following table illustrates the dilution:

Offering price per share $0.15
Net tangible book value per share as of December 31, 2018 $(0.0875 )
Increase in net tangible book value per share after this offering $(0.0041)
Pro forma net tangible book value per share after this offering $(0.916 )

Dilution per share to the investor in this offering $0.0584
👍️0
pberger pberger 6 년 전
As I said several times, no value here, but pure CRAP.
👍️0
ClayTrader ClayTrader 6 년 전
* * $HEB Video Chart 05-02-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Golden Cross Golden Cross 6 년 전
sinking fast here
👍️0
nokomis nokomis 6 년 전
price of warrants reduced to .15 bearish
👍️0
pberger pberger 6 년 전
This pure CRAP is now below the "good news" from 2 days ago, such a TURD!!!
👍️0
Golden Cross Golden Cross 6 년 전
Nasty... Looking to buy back in on a big dip today
👍️0
ClayTrader ClayTrader 6 년 전
* * $HEB Video Chart 05-01-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
Golden Cross Golden Cross 6 년 전
Nice news today!
👍️0
Zarate69 Zarate69 6 년 전
Dilution pure....
👍️0
tknuncle tknuncle 6 년 전
Where are all these shares coming from? It seems we have gone through all the OS after yesterday and this morning. We don't know what the float is but reading the OS at the OTC. So again were are all these shares coming from? The flippers have to be out now. Are the Shares being shorted by
the MM's? Again too new to trading to know what is going on with HEB..I would appreciate any input ;)
👍️0
aidytrader aidytrader 6 년 전
Where is the news? Thanks
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 6 년 전
$heb..huge news out today..shorts scrambling premarket...
👍️0
JJGl JJGl 6 년 전
26s!!
👍️0

최근 히스토리

Delayed Upgrade Clock